We have collected information about Plga Nanoparticles For Pulmonary Delivery for you. Follow the links to find out details on Plga Nanoparticles For Pulmonary Delivery.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013600/
Apr 08, 2014 · Pulmonary drug delivery is rapidly gaining importance, due to the multiple advantages. Lungs offer a vast variety of advantages over conventional oral drug delivery. The large surface area and the elimination of the first past effect makes the absorption of drugs in the lungs faster.Author: Mukta Paranjpe, Christel C. Müller-Goymann
https://www.sciencedirect.com/science/article/pii/S0731708517311780
Oct 25, 2017 · PLGA (50:50) nanoparticles were prepared to sustain the release of Ethionamide in order to decrease the dose and dosing frequency. It further modified in the form of dry powder inhaler to make suitable for pulmonary administration and increase drug residency in lungs.Author: Sujit Kumar Debnath, Srinivasan Saisivam, Abdelwahab Omri
https://www.sciencedirect.com/science/article/abs/pii/S0731708517311780
PLGA (50:50) nanoparticles were prepared to sustain the release of Ethionamide in order to decrease the dose and dosing frequency. It further modified in the form of dry powder inhaler to make suitable for pulmonary administration and increase drug residency in lungs.Author: Sujit Kumar Debnath, Srinivasan Saisivam, Abdelwahab Omri
https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.2042-7158.2012.01486.x
Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises Francesca Ungaro, Ivana d’ Angelo, Agnese Miro, Maria I. La Rotonda and Fabiana Quaglia ... nanoparticles for pulmonary delivery. The most promising particle engineeringAuthor: Francesca Ungaro, Ivana d' Angelo, Agnese Miro, Maria I. La Rotonda, Fabiana Quaglia
https://www.researchgate.net/publication/8499687_PLGA-PEI_nanoparticles_for_gene_delivery_to_pulmonary_epithelium
Benita et al. demonstrated the use of PEI in PLGA nanoparticles for the delivery of genes to the pulmonary epithelium [282]. Despite improvements in non-viral gene therapy strategies, there has ...
https://onlinelibrary.wiley.com/doi/full/10.1111/j.2042-7158.2012.01486.x
Mar 12, 2012 · It presents the rational of use, the potential and the recent advances in developing PLGA microparticles and nanoparticles for pulmonary delivery. The most promising particle engineering strategies are discussed, highlighting the advantages along with the major challenges for researchers working in this field.Author: Francesca Ungaro, Ivana d' Angelo, Agnese Miro, Maria I. La Rotonda, Fabiana Quaglia
https://link.springer.com/article/10.1007/s40005-019-00443-1
Apr 22, 2019 · The preparation and engineering of polymeric carriers for local (Tables 1 and 2) or systemic delivery (Table 3) of drugs to the lung is an attractive subject.In order to provide the proper therapeutic efficiency, drug deposition in the lung as well as drug release are required, which are influenced by the design of the carriers and the degradation rate of the polymers (Ali 2010).Author: Fakhrossadat Emami, Seyed Jamaleddin Mostafavi Yazdi, Dong Hee Na
https://www.mdpi.com/1424-8247/11/1/28/htm
Low Molecular Weight Chitosan-Coated PLGA Nanoparticles for Pulmonary Delivery of Tobramycin for Cystic Fibrosis. by Nusaiba K. Al-Nemrawi 1,*, Nid’’A H. Alshraiedeh 1, Aref L. Zayed 2 and Bashar M. Altaani 1. 1. Department of Pharmaceutical Technology, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan. 2.Author: Nusaiba K. Al-Nemrawi, Nid’’A H. Alshraiedeh, Aref L. Zayed, Bashar M. Altaani
https://www.ondrugdelivery.com/pulmonary-delivery-antimicrobial-peptides/
Citation: Fureby A, Elofsson U, Gerde P, “Pulmonary Delivery of Antimicrobial Peptides”. ONdrugDelivery Magazine, Issue 57 (Apr 2015), pp 4-7. Anna Fureby, Ulla Elofsson and Per Gerde discuss the serious problem of antibiotic resistance and the potential role of antimicrobial peptides in the treatment of resistant bacterial strains.
https://journal.pda.org/content/64/3/278
May 01, 2010 · Lactose-Conjugated PLGA Nanoparticles for Enhanced Delivery of Rifampicin to the Lung for Effective Treatment of Pulmonary TuberculosisAuthor: Jain Sk, Gupta Y, Ramalingam L, Jain A, Khare P, Bhargava D
Searching for Plga Nanoparticles For Pulmonary Delivery?
You can just click the links above. The data is collected for you.
